Llwytho...
Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers
Approximately 75% of breast tumors express the estrogen receptor (ER), and women with these tumors will receive endocrine therapy. Unfortunately, up to 50% of these patients will fail ER-targeted therapies due to either de novo or acquired resistance. ER-positive tumors can be classified based on ge...
Wedi'i Gadw mewn:
| Fformat: | Erthygl |
|---|---|
| Iaith: | en |
| Cyhoeddwyd: |
Endocrine Society
2012
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3286192/ https://ncbi.nlm.nih.gov/pubmed/22301780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/me.2011-1302 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|